Table 4.
Laboratory findings before and after treatment
| Treatment option | Laboratory parameter | Before treatment | After treatment |
|---|---|---|---|
| Plasma exchange + glucocorticoids + immunosuppressive agent (n = 10) |
Leukocyte | 3.41 (3.54) | 6.28 (4.99) |
| Platelet | 40 (54) | 132.5 (86.25) | |
| Hemoglobin | 62.5 (26.25) | 88.0 (15.25) | |
| LDH | 528 (386) | 286 (78) | |
| Creatinine | 115 (136) | 78 (67) | |
| Urea | 17.3 (21) | 10.69 (14.6) | |
| Glucocorticoids + immunosuppressive agent (n = 13) |
Leukocyte | 6.97 (7.07) | 6.95 (4.54) |
| Platelet | 38 (53.25) | 159 (36) | |
| Hemoglobin | 71 (36.35) | 106 (45.75) | |
| LDH | 541 (300) | 242 (233) | |
| Creatinine | 187 (133) | 83 (85) | |
| Urea | 17.94 (5.97) | 7.1 (13.85) | |
| Plasma exchangea + glucocorticoids (n = 1) |
Leukocyte | 2.42 | 6.55 |
| Platelet | 61 | 279 | |
| Hemoglobin | 81 | 131 | |
| LDH | 691 | 296 | |
| Creatinine | 407 | 279 | |
| Urea | 32.5 | 15.7 | |
| Plasma exchange + glucocorticoids + immunosuppressive agent + Rituximab (n = 1) |
Leukocyte | 2.7 | 3.5 |
| Platelet | 59 | 108 | |
| Hemoglobin | 85 | 74 | |
| LDH | 619 | 246 | |
| Creatinine | 407 | 279 | |
| Urea | 38.2 | 27.7 |
aPlasma exchange was performed four times